 by the PBM, which limits patient choice and competition. That leads to higher costs for the consumer. And lastly, and this is where the government really needs to take a look, and some states have already started, is anti-competitive practices. So PBMs are engaging in these types of practices and using their market power to negotiate lower prices from pharmacies.